Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001521802 | SCV001731209 | benign | not provided | 2023-08-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001521802 | SCV002000364 | uncertain significance | not provided | 2020-12-01 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Genome Diagnostics Laboratory, |
RCV002276757 | SCV002566975 | uncertain significance | Connective tissue disorder | 2020-03-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003908871 | SCV004724182 | likely benign | PTH1R-related disorder | 2020-07-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |